Rasha Aboelhassan: The enemy is called metastasis of unknown primary
Rasha Aboelhassan shared on LinkedIn:
“Have you ever met that enemy who hides far away so that you can never see him but you can only discover and see his actions results?
Have you ever met the enemy that you can only discover his presence after metastasising in bone, brain, liver, and lung?
With him, you can never know the origin so that you can’t put any plans for effective defence actions. Even after biopsy, IHC, and molecular subtypes, we lose many patients without discovering the primary. This enemy is called: metastasis of unknown primary.
I was very impressed with the idea of the following research, whereas investigators looked for new methods for the detection of primary and discover the origin of our cancer enemy. Hopefully we all can one day.”
Source: Rasha Aboelhassan/LinkedIn
Authors: Fei Tian, Dong Liu, Na Wei, Qianqian Fu, Lin Sun, Wei Liu, Xiaolong Sui, Kathryn Tian, Genevieve Nemeth, Jingyu Feng, Jingjing Xu, Lin Xiao, Junya Han, Jingjie Fu, Yinhua Shi, Yichen Yang, Jia Liu, Chunhong Hu, Bin Feng, Yan Sun, Yunjun Wang, Guohua Yu, Dalu Kong, Meiyun Wang, Wencai Li, Kexin Chen, Xiangchun Li
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
Rasha Aboelhassan is a Senior Oncology Consultant at Nasser Institute Hospital. In addition to her clinical role, she volunteers as a reviewer for the World Journal of Surgical Oncology, contributing to advancements in the field and is in the Editorial Staff of Egyptian Journal of Human Genetics.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023